Skip to main content
NEU job vacancy
Worth the risk?
A new funding agency for science claims it will be tolerant of failure – but the signs are that it aims only to replicate existing venture capitalism, write ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
CUTTING EDGE: Smart Tissue Autonomous Robot (STAR) which can perform laparoscopic surgery on the soft tissue of a pig without human help

LAST month the Advanced Research and Invention Agency (Aria) announced the appointment of a new CEO, in line with its intention to launch around the end of this year.

Aria is a new funding agency modelled on venture capital funding for high-risk “moonshot” research that will sit alongside, although independent of the umbrella British research funding agency UK Research and Innovation.

The new CEO, Ilan Gur, has a background in venture capital.  

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
Similar stories
POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

SCIENCE AND SOCIETY / 22 April 2025
22 April 2025

Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

GROUP SUPREMACY: Alois Alzheimer (standing third from right)
Science and Society / 11 February 2025
11 February 2025
Fraud in Alzheimer’s research raises difficult questions about the current state of science, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
BIG BUSINESS AGENDA: Donald Trump
Science and Society / 29 January 2025
29 January 2025
The new US administration’s policy decisions are already having seismic effects worldwide, argue ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT